Drugs / Balance multivitamin tablets
Balance multivitamin tablets
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06981936 | May 2025 → May 2026 overdue | nutritional deficiency disease | General Committee of Teaching Hospitals and Institutes, Egypt | Recruiting | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Balance multivitamin tablets | “Evaluate the efficacy of daily Balance multivitamin tablets in reducing the incidence of vitamin and mineral deficiencies among patients undergoing treatment with GLP-1...” NCT06981936 ↗ |
| Known as | Balance Tablet | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06981936 ↗ |
| Known as | Balance Tablets | “Evaluation of Balance Tablets in Reducing Vitamin and Mineral Deficiencies in Patients Using GLP-1 Receptor Agonists for Weight Loss” NCT06981936 ↗ |
| Known as | Balanced nutritional tablets | “To address this gap, this randomized trial aims to investigate the efficacy of Balanced nutritional tablets-comprehensive multivitamin and mineral supplements- in preventing...” NCT06981936 ↗ |
| Modality | Other / unclassified | “Balanced nutritional tablets-comprehensive multivitamin and mineral supplements” NCT06981936 ↗ |
| Route | Oral | “Participants take one Balance multivitamin/mineral tablet daily for 12 months.” NCT06981936 ↗ |